A NIR-light activated nanoplatform for sensitizing triple negative breast cancer against therapeutic resistance to enhance the treatment effect-Reference-Cited by-同舟云学术

A NIR-light activated nanoplatform for sensitizing triple negative breast cancer against therapeutic resistance to enhance the treatment effect

Published:2018 Issue:43 Volume:6 Page:6950-6956
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Sun Xiaojing¹²³,Jin Yi⁴²³,Wang Hao¹²³,Feng Na¹²³,Li Zhenhua¹²³,Liu Dandan¹²³,Ge Kun¹²³,Liu Huifang¹²³,Zhang Jinchao¹²³^ORCID,Yang Xinjian¹²³^ORCID

Affiliation:

1. College of Chemistry & Environmental Science, Chemical Biology Key Laboratory of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Hebei University

2. Baoding 071002

3. P. R. China

4. College of Medical Science, Hebei University

Abstract

A NIR-light activated combination therapeutic nanoplatform is reported to cure TNBC by gene-silencing based sensitization of cancer cells toward treatment.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hebei Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2018/TB/C8TB01723A

Reference32 articles.

1. Triple-negative breast cancer: disease entity or title of convenience?

2. Magnetically Triggered Dual Functional Nanoparticles for Resistance-Free Apoptotic Hyperthermia